Assessing Cancer Risk Associated with Immunosuppressive TherapiesÂ
Over the past few decades, the dermatologic care of inflammatory skin conditions has been transformed through the growing use of small molecules disease-modifying anti-rheumatic drugs (DMARDs) and targeted biologic therapies. However, alongside the tremendous benefits offered by these therapeutic agents are concerns regarding potential adverse effects, in particular associated risks of cancer development. The controversial […]
Growing Evidence of Increased Cancer Risk in Psoriasis Patients
Often triggered by stress, infections, and certain medications, the chronic inflammatory skin condition psoriasis affects up to 125 million patients worldwide. The skin disorder has been linked to decreased quality of life, along with an increased risk of comorbid conditions. In recent years, the association between psoriasis and risk of cancer has been controversial with […]
